HEADER LIGASE/PEPTIDE 02-JUN-14 2MPS TITLE STRUCTURE OF COMPLEX OF MDM2(3-109) AND P73 TAD(10-25) COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE MDM2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 3-109; COMPND 5 SYNONYM: DOUBLE MINUTE 2 PROTEIN, HDM2, ONCOPROTEIN MDM2, P53-BINDING COMPND 6 PROTEIN MDM2; COMPND 7 EC: 6.3.2.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: TUMOR PROTEIN P73; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: UNP RESIDUES 10-25; COMPND 13 SYNONYM: P53-LIKE TRANSCRIPTION FACTOR, P53-RELATED PROTEIN; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MDM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: P73, TP73; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 18 EXPRESSION_SYSTEM_VECTOR: PET KEYWDS MDM2, P73 TAD, P53, LIGASE-PEPTIDE COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 MDLTYP MINIMIZED AVERAGE AUTHOR J.S.SHIN,J.H.HA,S.W.CHI REVDAT 2 14-JUN-23 2MPS 1 REMARK REVDAT 1 03-JUN-15 2MPS 0 JRNL AUTH J.S.SHIN,J.H.HA,D.H.LEE,K.S.RYU,K.H.BAE,B.C.PARK,S.G.PARK, JRNL AUTH 2 G.S.YI,S.W.CHI JRNL TITL STRUCTURAL CONVERGENCE OF UNSTRUCTURED P53 FAMILY JRNL TITL 2 TRANSACTIVATION DOMAINS IN MDM2 RECOGNITION JRNL REF CELL CYCLE V. 14 533 2015 JRNL REFN ISSN 1538-4101 JRNL PMID 25591003 JRNL DOI 10.1080/15384101.2014.998056 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR_NIH_2.26 REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MPS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000103904. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 283 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.9 MM [U-99% 13C; U-99% 15N] E3 REMARK 210 UBIQUITIN-PROTEIN LIGASE MDM2-1, REMARK 210 90% H2O/10% D2O; 0.9 MM [U-99% REMARK 210 13C; U-99% 15N] TUMOR PROTEIN REMARK 210 P73-2, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 3D CBCA(CO)NH; 3D REMARK 210 HNCO; 3D HNCACB; 3D HBHA(CO)NH; REMARK 210 3D HCCH-TOCSY; 3D HCCH-COSY; 3D REMARK 210 1H-15N NOESY; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA, NMRDRAW, SPARKY, TALOS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HZ1 LYS A 45 OE2 GLU A 52 1.58 REMARK 500 OD1 ASP B 301 HG1 THR B 304 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 16 -65.92 -101.72 REMARK 500 2 PRO A 9 89.65 -61.37 REMARK 500 2 VAL A 14 95.01 -69.31 REMARK 500 2 THR A 16 -60.09 -129.93 REMARK 500 2 CYS A 77 28.32 48.91 REMARK 500 3 CYS A 77 28.14 48.57 REMARK 500 3 THR B 304 -66.72 -91.07 REMARK 500 4 THR A 4 -74.86 -131.69 REMARK 500 4 CYS A 77 27.29 49.23 REMARK 500 5 PRO A 9 108.18 -49.59 REMARK 500 5 THR A 10 -79.25 -148.44 REMARK 500 5 ASP A 11 -39.58 -145.05 REMARK 500 5 ARG A 65 66.33 62.63 REMARK 500 6 ASN A 5 95.96 72.77 REMARK 500 6 MET A 6 -70.21 -70.91 REMARK 500 6 PRO A 9 101.11 -56.44 REMARK 500 6 ALA A 21 75.20 58.29 REMARK 500 6 ARG A 65 66.58 60.96 REMARK 500 6 TYR A 76 -61.19 -94.69 REMARK 500 7 THR A 4 100.94 -59.22 REMARK 500 7 THR A 15 -71.24 -128.41 REMARK 500 7 ARG A 65 67.41 64.11 REMARK 500 7 TYR A 76 -68.34 -96.24 REMARK 500 8 THR A 4 110.58 65.61 REMARK 500 8 THR A 15 99.25 -64.88 REMARK 500 8 TYR A 76 -66.30 -98.56 REMARK 500 9 ASN A 5 -99.03 -97.95 REMARK 500 9 TYR A 76 -69.70 -98.46 REMARK 500 9 THR B 304 -81.27 51.83 REMARK 500 10 THR A 26 -71.19 -138.07 REMARK 500 10 ARG A 65 67.57 72.36 REMARK 500 10 TYR A 76 -69.03 -107.30 REMARK 500 10 THR B 304 -91.00 -79.39 REMARK 500 11 SER A 7 -48.06 -167.28 REMARK 500 11 ARG A 65 66.33 63.58 REMARK 500 12 ASP A 11 -67.23 -125.32 REMARK 500 12 VAL A 14 41.53 -80.46 REMARK 500 12 THR A 15 96.97 -69.11 REMARK 500 12 ARG A 65 62.31 64.71 REMARK 500 12 TYR A 76 -68.82 -91.69 REMARK 500 12 ASP A 80 -169.53 -108.07 REMARK 500 13 GLN A 24 77.53 56.69 REMARK 500 13 GLU A 25 -70.14 -85.80 REMARK 500 13 ARG A 65 63.84 64.75 REMARK 500 13 THR B 304 114.07 59.11 REMARK 500 14 SER A 22 -59.69 -150.93 REMARK 500 14 GLN A 24 -177.05 64.25 REMARK 500 14 PRO A 30 113.76 -16.14 REMARK 500 14 ARG A 65 66.42 62.71 REMARK 500 14 TYR A 76 -69.63 -91.79 REMARK 500 REMARK 500 THIS ENTRY HAS 73 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18876 RELATED DB: BMRB DBREF 2MPS A 3 109 UNP Q00987 MDM2_HUMAN 3 109 DBREF 2MPS B 301 316 UNP O15350 P73_HUMAN 10 25 SEQRES 1 A 107 ASN THR ASN MET SER VAL PRO THR ASP GLY ALA VAL THR SEQRES 2 A 107 THR SER GLN ILE PRO ALA SER GLU GLN GLU THR LEU VAL SEQRES 3 A 107 ARG PRO LYS PRO LEU LEU LEU LYS LEU LEU LYS SER VAL SEQRES 4 A 107 GLY ALA GLN LYS ASP THR TYR THR MET LYS GLU VAL LEU SEQRES 5 A 107 PHE TYR LEU GLY GLN TYR ILE MET THR LYS ARG LEU TYR SEQRES 6 A 107 ASP GLU LYS GLN GLN HIS ILE VAL TYR CYS SER ASN ASP SEQRES 7 A 107 LEU LEU GLY ASP LEU PHE GLY VAL PRO SER PHE SER VAL SEQRES 8 A 107 LYS GLU HIS ARG LYS ILE TYR THR MET ILE TYR ARG ASN SEQRES 9 A 107 LEU VAL VAL SEQRES 1 B 16 ASP GLY GLY THR THR PHE GLU HIS LEU TRP SER SER LEU SEQRES 2 B 16 GLU PRO ASP HELIX 1 1 LYS A 31 SER A 40 1 10 HELIX 2 2 THR A 49 ARG A 65 1 17 HELIX 3 3 ASP A 80 GLY A 87 1 8 HELIX 4 4 GLU A 95 ARG A 105 1 11 HELIX 5 5 THR B 305 SER B 312 1 8 SHEET 1 A 2 ILE A 74 VAL A 75 0 SHEET 2 A 2 PHE A 91 SER A 92 -1 O PHE A 91 N VAL A 75 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1